BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15516685)

  • 1. Severe breathlessness, mouth ulcers and skin blistering in a female.
    Gudi VS; Ormerod AD; Weir J; Kerr KM; Devereux G
    Eur Respir J; 2004 Nov; 24(5):884-7. PubMed ID: 15516685
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma.
    Morikawa K; Tsuji T; Yamasaki H; Egashira S; Kaguchi A; Kido M; Tsuda H
    Acta Haematol; 2014; 132(1):73-4. PubMed ID: 24481059
    [No Abstract]   [Full Text] [Related]  

  • 3. Paraneoplastic pemphigus with bronchiolitis obliterans in a child.
    Mar WA; Glaesser R; Struble K; Stephens-Groff S; Bangert J; Hansen RC
    Pediatr Dermatol; 2003; 20(3):238-42. PubMed ID: 12787274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of paraneoplastic pemphigus associated with retroperitoneal diffuse large B-cell lymphoma and fatal bronchiolitis obliterans-like lung disease.
    Suzuki K; Nishiwaki K; Yamada H; Baba H; Hori K; Takeuchi T; Fukuda S; Hashimoto T
    J Dermatol; 2013 Feb; 40(2):142-4. PubMed ID: 23110627
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus.
    Kishi T; Nakata J; Yamada T; Nakatsuka S; Matsuura A; Shibano M
    Ann Hematol; 2022 Feb; 101(2):453-455. PubMed ID: 33754167
    [No Abstract]   [Full Text] [Related]  

  • 6. Paraneoplastic pemphigus.
    Zhu X; Zhang B
    J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic pemphigus with Castleman's disease and bronchiolitis obliterans.
    Jindal T; Meena M; Kumar A; Khaitan BK
    Pediatr Int; 2011 Dec; 53(6):1108-9. PubMed ID: 22181577
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine.
    Kuriyama K; Kitamura Y; Tsuji T; Nishikawa R; Nagata H; Ohshiro M; Sugitani M; Hirakawa Y; Matsumoto Y; Iwai T; Uchiyama H
    Curr Probl Cancer; 2022 Apr; 46(2):100813. PubMed ID: 34844771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Follicular lymphoma accompanied by paraneoplastic pemphigus and bronchiolitis obliterans: a case report].
    Watanabe K; Yoshifuji K; Saito T; Yamashita T; Nogami A; Sakashita C; Fukuda T; Arai A; Tohda S; Kawamata N; Miura O; Yamamoto M
    Rinsho Ketsueki; 2019; 60(1):7-11. PubMed ID: 30726827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
    Moustafa MA; Seningen JL; Jouni H; Singh PP; el-Azhary RA; Witzig TE
    Am J Hematol; 2013 Sep; 88(9):822-3. PubMed ID: 23658142
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchiolitis obliterans presenting as prolonged ventilator dependence in a patient with paraneoplastic pemphigus.
    Saito S; Sanui M; Fujii T; Endo A; Saito K; Iwai K; Uchino S; Takinawi M
    Anaesth Intensive Care; 2012 Jul; 40(4):726-8. PubMed ID: 22813514
    [No Abstract]   [Full Text] [Related]  

  • 12. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
    Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
    J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic pemphigus associated with bronchiolitis obliterans.
    Takahashi M; Shimatsu Y; Kazama T; Kimura K; Otsuka T; Hashimoto T
    Chest; 2000 Feb; 117(2):603-7. PubMed ID: 10669715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus.
    Borradori L; Lombardi T; Samson J; Girardet C; Saurat JH; Hügli A
    Arch Dermatol; 2001 Mar; 137(3):269-72. PubMed ID: 11255323
    [No Abstract]   [Full Text] [Related]  

  • 15. Bronchiolitis obliterans, Castleman's disease, and a bullous disease: pemphigus vulgaris or paraneoplastic pemphigus?
    Pizarro A; García-Tobaruela A; Pinilla J
    Hum Pathol; 1998 Jun; 29(6):657-8. PubMed ID: 9635692
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterisation of inflammatory infiltrates in lesions of the oral mucosa, skin, and bronchioles in a case of paraneoplastic pemphigus.
    Iida K; Yamaguchi F; Hibi K; Tate G; Ohyama B; Numata S; Hashimoto T; Sato M; Uchida T; Sueki H
    Eur J Dermatol; 2012; 22(1):154-5. PubMed ID: 22370168
    [No Abstract]   [Full Text] [Related]  

  • 17. Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome.
    Maldonado F; Pittelkow MR; Ryu JH
    Respirology; 2009 Jan; 14(1):129-33. PubMed ID: 19144057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of respiratory failure in paraneoplastic pemphigus.
    Nousari HC; Deterding R; Wojtczack H; Aho S; Uitto J; Hashimoto T; Anhalt GJ
    N Engl J Med; 1999 May; 340(18):1406-10. PubMed ID: 10228191
    [No Abstract]   [Full Text] [Related]  

  • 19. Bronchiolitis Obliterans With Anti-Epiplakin Antibodies in a Boy With Paraneoplastic Pemphigus.
    Rivas-Calderon M; Yamazaki-Nakashimada MA; Orozco-Covarrubias L; Durán-McKinster C; Pacheco-Tovar D; Ávalos-Díaz E; Sáez-de-Ocariz M
    Pediatrics; 2022 Mar; 149(3):. PubMed ID: 35118492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic pemphigus associated with Castleman's disease and asymptomatic bronchiolitis obliterans.
    Fujimoto W; Kanehiro A; Kuwamoto-Hara K; Saitoh M; Nakakita T; Amagai M; Arata J; Iwatsuki K
    Eur J Dermatol; 2002; 12(4):355-9. PubMed ID: 12095881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.